These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5715439)

  • 1. [Functional and histological studies of the effect of a modified high molecular weight gelatin preparation on the kidneys].
    Hölscher B
    Chirurg; 1968 May; 39(5):228-30. PubMed ID: 5715439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative functional and light microscopic studies on the renal effect of extreme blood dilution using Rheomacrodex, Haemaccel or tutofusin].
    Hölscher B
    Langenbecks Arch Chir; 1968; 320(2):100-10. PubMed ID: 5670146
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of the gelatin expander physiogel on kidney function].
    Cottier P; Basevi A; Schafroth HJ
    Helv Chir Acta; 1966 May; 33(3):383-91. PubMed ID: 5994658
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of gelatin infusions on the intravascular fluid volume in non-pregnant and pregnant women.
    Göltner E
    Bibl Haematol; 1969; 33():184-93. PubMed ID: 5377191
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental study on modified fluid gelatin as a serum volume expander].
    Murakami S; Hamabe N; Kitani M; Ota Y; Tanigawa H
    Masui; 1969 Jun; 18(6):500-9. PubMed ID: 5816994
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of blood substitution of equal volume by a higher-molecular gelatine preparation following hypotension induced by blood withdrawal].
    Hölscher B
    Arzneimittelforschung; 1970 Dec; 20(12):1901-4. PubMed ID: 5537093
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal function in baboon kidneys during hypotensive, isolated, bloodless perfusion with oxygen or helium gas. Responses to a gelatine plasma substitute.
    Murphy GP; Groenewald JH; Schoonees R; Retief CP; van Zyl JJ; de Klerk JN
    Invest Urol; 1969 Jan; 6(4):348-55. PubMed ID: 4975261
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of Gelafusal infusion on renal function].
    Rusiniak L; Sitarska E; Zienkiewicz K; Scharf R; Kostrzewska E; Kluciński W; Sokołowska K; Gregor A
    Pol Tyg Lek; 1978 Aug; 33(32):1245-7. PubMed ID: 704420
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental studies on the cardiovascular effect of a 3.5 percent gelatin solution for infusion].
    Retzke U; Schwarz R
    Z Exp Chir; 1973; 6(4):227-36. PubMed ID: 4772913
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the effect of plasma volume substitutes on the kidneys in acute blood volume deficiency].
    Hölscher B
    Chirurg; 1968 Apr; 39(4):178-81. PubMed ID: 5687669
    [No Abstract]   [Full Text] [Related]  

  • 11. [Does gelatin as a blood substitute selectively depress plasma fibronectin? A clinical randomized study].
    Lackner F; Graninger W; Khosropour R
    Anaesthesist; 1985 Sep; 34(9):470-3. PubMed ID: 3909842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions.
    Thaler U; Deusch E; Kozek-Langenecker SA
    Anaesthesia; 2005 Jun; 60(6):554-9. PubMed ID: 15918826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [1st clinical trial of a new high-molecular-weight, gelatin-based plasma substitute].
    Scholz PM; Rittmann WW; Müller W; Leutenegger A; Gruber UF
    Schweiz Med Wochenschr; 1971 Jul; 101(27):987-94. PubMed ID: 5169067
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation studies on a 4 per cent gelatin solution containing 1 per cent glycine for intravenous use.
    Gabr Y; Saleeb F; Osman M
    Arzneimittelforschung; 1967 May; 17(5):643-5. PubMed ID: 5631598
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative histologic investigations on the effect of repeated intravenous injections of large quantities of isogenous blood plasma and Physiogel in mice].
    Cottier H
    Helv Chir Acta; 1966 May; 33(3):376-82. PubMed ID: 5994657
    [No Abstract]   [Full Text] [Related]  

  • 16. [Renal function, blood volume reaction and hemostatic changes after an infusion of a plasma substitute with a gelatin base].
    Pflueger H
    Rev Bras Anestesiol; 1969; 19(2):260-70. PubMed ID: 5352461
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of gelatinous priming solution for extracorporeal circulation.
    Silvay J; Sujanský E; Schnorrer M; Hrubisková K; Slezák J; Gabauer I; Styk J
    J Thorac Cardiovasc Surg; 1968 Mar; 55(3):350-8. PubMed ID: 5642701
    [No Abstract]   [Full Text] [Related]  

  • 18. Is coating of tubing required when endothelin-1 is infused intravenously?
    Vuurmans T; Koomans H; Boer P
    Nephrol Dial Transplant; 2003 Aug; 18(8):1677-8. PubMed ID: 12897117
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxyethylstarch 200 and 240 differently affect aortic distensibility but not viscosity and blood pressure upon acute isovolumic hemodilution.
    Caron A; Hacquard M; Audibert G; Cauchois G; Vigneron C; Stoltz JF; Longrois D; Menu P
    Clin Hemorheol Microcirc; 2006; 35(4):447-58. PubMed ID: 17148843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacodynamics of plasma substitutes].
    Mas Marfany J
    Rev Esp Anestesiol Reanim; 1971 Jan; 18(1):108-14. PubMed ID: 5552978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.